ZA966163B - Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives. - Google Patents
Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.Info
- Publication number
- ZA966163B ZA966163B ZA9606163A ZA966163A ZA966163B ZA 966163 B ZA966163 B ZA 966163B ZA 9606163 A ZA9606163 A ZA 9606163A ZA 966163 A ZA966163 A ZA 966163A ZA 966163 B ZA966163 B ZA 966163B
- Authority
- ZA
- South Africa
- Prior art keywords
- derivatives
- pharmaceutical compositions
- compositions containing
- preparation
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514821.9A GB9514821D0 (en) | 1995-07-19 | 1995-07-19 | Galanthamine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA966163B true ZA966163B (en) | 1997-02-10 |
Family
ID=10777948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9606163A ZA966163B (en) | 1995-07-19 | 1996-07-19 | Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5958903A (xx) |
EP (1) | EP0839149B9 (xx) |
JP (1) | JP4177894B2 (xx) |
AT (1) | ATE264332T1 (xx) |
AU (1) | AU6662396A (xx) |
CA (1) | CA2227235C (xx) |
DE (1) | DE69632194T2 (xx) |
DK (1) | DK0839149T3 (xx) |
ES (1) | ES2218596T3 (xx) |
GB (1) | GB9514821D0 (xx) |
IL (1) | IL122739A0 (xx) |
MX (1) | MX9800407A (xx) |
NO (1) | NO980215L (xx) |
PT (1) | PT839149E (xx) |
WO (1) | WO1997003987A1 (xx) |
ZA (1) | ZA966163B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1891954A3 (en) * | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
JP5558648B2 (ja) | 1998-11-23 | 2014-07-23 | デイビス、ボニー | アセチルコリンエステラーゼ阻害剤のための投与製剤 |
PT1140105E (pt) | 1998-12-24 | 2004-03-31 | Janssen Pharmaceutica Nv | Composicao de galantamina de libertacao controlada |
US8603546B2 (en) * | 1999-01-11 | 2013-12-10 | Herbaceuticals Inc. | Herbal supplement for increased muscle strength and endurance for athletes |
ATE355066T1 (de) * | 1999-01-11 | 2006-03-15 | Atanas Russinov Djananov | Nahrungszusatz aus kräutern zur steigerung der muskulären kraft und ausdauer von athleten |
WO2000059544A1 (fr) * | 1999-03-31 | 2000-10-12 | Eisai Co., Ltd. | Compositions stabilisees contenant des medicaments nootropes |
EP1181294B1 (de) * | 2000-03-31 | 2004-03-31 | Sanochemia Pharmazeutika Aktiengesellschaft | Neue derivate und analoga von galanthamin |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
EP1681291A1 (de) * | 2002-03-25 | 2006-07-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Verfahren zur Herstellung von Norgalanthamin, Ihren Isomeren, Salzen und Hydraten |
EP1667769A2 (de) * | 2003-09-29 | 2006-06-14 | Sanochemia Pharmazeutica Aktiengesellschaft | Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
WO2005065661A2 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galanthamine |
EP2316437B1 (en) * | 2005-05-13 | 2014-07-30 | Alza Corporation | Multilayer drug delivery system with barrier against reservoir material flow |
WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
CN102149398B (zh) * | 2008-09-11 | 2013-12-04 | I·B·R·以色列生物科技研究有限公司 | 雪片莲属鳞茎提取物及其用途 |
CN102573848A (zh) * | 2009-04-24 | 2012-07-11 | 济州大学校产学协力团 | 含有去甲加兰他敏化合物作为活性成分的用于预防和治疗脱发症的组合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
US4735169A (en) * | 1986-09-03 | 1988-04-05 | Nordson Corporation | Adhesive applicator assembly |
AU632458B2 (en) * | 1987-05-04 | 1993-01-07 | Bonnie Davis | Compounds for the treatment of alzheimer's disease |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1995
- 1995-07-19 GB GBGB9514821.9A patent/GB9514821D0/en active Pending
-
1996
- 1996-07-19 DE DE69632194T patent/DE69632194T2/de not_active Expired - Lifetime
- 1996-07-19 PT PT96926431T patent/PT839149E/pt unknown
- 1996-07-19 IL IL12273996A patent/IL122739A0/xx unknown
- 1996-07-19 AT AT96926431T patent/ATE264332T1/de active
- 1996-07-19 ES ES96926431T patent/ES2218596T3/es not_active Expired - Lifetime
- 1996-07-19 WO PCT/FR1996/001139 patent/WO1997003987A1/fr active IP Right Grant
- 1996-07-19 AU AU66623/96A patent/AU6662396A/en not_active Abandoned
- 1996-07-19 MX MX9800407A patent/MX9800407A/es unknown
- 1996-07-19 US US08/983,309 patent/US5958903A/en not_active Expired - Lifetime
- 1996-07-19 EP EP96926431A patent/EP0839149B9/fr not_active Expired - Lifetime
- 1996-07-19 JP JP50637297A patent/JP4177894B2/ja not_active Expired - Fee Related
- 1996-07-19 ZA ZA9606163A patent/ZA966163B/xx unknown
- 1996-07-19 DK DK96926431T patent/DK0839149T3/da active
- 1996-07-19 CA CA2227235A patent/CA2227235C/fr not_active Expired - Fee Related
-
1998
- 1998-01-16 NO NO980215A patent/NO980215L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1997003987A1 (fr) | 1997-02-06 |
AU6662396A (en) | 1997-02-18 |
NO980215D0 (no) | 1998-01-16 |
DK0839149T3 (da) | 2004-08-09 |
MX9800407A (es) | 1998-04-30 |
ATE264332T1 (de) | 2004-04-15 |
EP0839149A1 (fr) | 1998-05-06 |
EP0839149B1 (fr) | 2004-04-14 |
PT839149E (pt) | 2004-08-31 |
JP4177894B2 (ja) | 2008-11-05 |
JPH11509541A (ja) | 1999-08-24 |
EP0839149B9 (fr) | 2005-03-09 |
NO980215L (no) | 1998-01-16 |
GB9514821D0 (en) | 1995-09-20 |
US5958903A (en) | 1999-09-28 |
CA2227235A1 (fr) | 1997-02-06 |
IL122739A0 (en) | 1998-08-16 |
CA2227235C (fr) | 2010-08-31 |
ES2218596T3 (es) | 2004-11-16 |
DE69632194T2 (de) | 2005-03-17 |
DE69632194D1 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA966163B (en) | Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives. | |
GEP20012375B (en) | Isothiazolones, Pharmaceutical Composition on Their Basis and Method for Obtaining the Same | |
EG22373A (en) | New pharmaceutical formulation | |
MX9700223A (es) | Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida. | |
CZ58196A3 (en) | Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof | |
HUP0100731A3 (en) | New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them | |
HUP9900056A2 (hu) | Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
ZA965969B (en) | Salts derived from amidine and cyclooxygenase inhibitor process for the preparation thereof their application as medicinal drugs and pharmaceutical compositions in which they are contained | |
CZ129596A3 (en) | Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof | |
HUP9702400A3 (en) | Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9602635A3 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU5644196A (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
HUP9601062A2 (en) | Chromone derivatives, pharmaceutical compositions containing them and process for their preparation | |
HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them | |
HUP9600173A2 (en) | 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
ZA969319B (en) | Derivatives of imidazole n-benzyldioxole, their preparation process, their use as medicaments, pharmaceutical composition and new use. | |
GR3034886T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
GEP20012518B (en) | Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine | |
HU9503345D0 (en) | Substituted benzoyl-guanidine derivatives, process for producing them their use as medicine and diagnosticum and pharmaceutical composition containing them | |
HRP980527B1 (en) | Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them | |
EP0813415A4 (en) | THIONOPHOSPHATE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
HUP9901458A3 (en) | Crystal form ii. of tazofelone, process for preparation thereof, use and pharmaceutical composition containing the same |